208 related articles for article (PubMed ID: 32572171)
1. Gremlin-1 augments the oestrogen-related receptor α signalling through EGFR activation: implications for the progression of breast cancer.
Park SA; Sung NJ; Choi BJ; Kim W; Kim SH; Surh YJ
Br J Cancer; 2020 Sep; 123(6):988-999. PubMed ID: 32572171
[TBL] [Abstract][Full Text] [Related]
2. Gremlin-1 Promotes Metastasis of Breast Cancer Cells by Activating STAT3-MMP13 Signaling Pathway.
Sung NJ; Kim NH; Surh YJ; Park SA
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33287358
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression.
Ren J; Smid M; Iaria J; Salvatori DCF; van Dam H; Zhu HJ; Martens JWM; Ten Dijke P
Breast Cancer Res; 2019 Sep; 21(1):109. PubMed ID: 31533776
[TBL] [Abstract][Full Text] [Related]
4. GREM1 is associated with metastasis and predicts poor prognosis in ER-negative breast cancer patients.
Neckmann U; Wolowczyk C; Hall M; Almaas E; Ren J; Zhao S; Johannessen B; Skotheim RI; Bjørkøy G; Ten Dijke P; Holien T
Cell Commun Signal; 2019 Nov; 17(1):140. PubMed ID: 31694641
[TBL] [Abstract][Full Text] [Related]
5. Gremlin-1 activates Akt/STAT3 signaling, which increases the glycolysis rate in breast cancer cells.
Kim NH; Sung NJ; Youn HS; Park SA
Biochem Biophys Res Commun; 2020 Dec; 533(4):1378-1384. PubMed ID: 33097188
[TBL] [Abstract][Full Text] [Related]
6. DHA inhibits Gremlin-1-induced epithelial-to-mesenchymal transition via ERK suppression in human breast cancer cells.
Sung NJ; Kim NH; Bae NY; Jo HS; Park SA
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32141512
[TBL] [Abstract][Full Text] [Related]
7. GREM1 overexpression inhibits proliferation, migration and angiogenesis of osteosarcoma.
Gu Q; Luo Y; Chen C; Jiang D; Huang Q; Wang X
Exp Cell Res; 2019 Nov; 384(1):111619. PubMed ID: 31525341
[TBL] [Abstract][Full Text] [Related]
8. First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor-positive breast cancer.
Helms MW; Packeisen J; August C; Schittek B; Boecker W; Brandt BH; Buerger H
J Pathol; 2005 Jul; 206(3):366-76. PubMed ID: 15892165
[TBL] [Abstract][Full Text] [Related]
9. He-Chan Pian inhibits the metastasis of non-small cell lung cancer via the miR-205-5p-mediated regulation of the GREM1/Rap1 signaling pathway.
Kan J; Fu B; Zhou R; Zhou D; Huang Y; Zhao H; Zhang Y; Rong Y; Dong J; Xia L; Liu S; Huang Q; Wang N; Ning N; Zhang B; Zhang E
Phytomedicine; 2022 Jan; 94():153821. PubMed ID: 34752967
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor-induced signaling in breast cancer cells results in selective target gene activation by orphan nuclear receptor estrogen-related receptor alpha.
Barry JB; Giguère V
Cancer Res; 2005 Jul; 65(14):6120-9. PubMed ID: 16024613
[TBL] [Abstract][Full Text] [Related]
11. Gremlin-1: An endogenous BMP antagonist induces epithelial-mesenchymal transition and interferes with redifferentiation in fetal RPE cells with repeated wounds.
Li D; Yuan D; Shen H; Mao X; Yuan S; Liu Q
Mol Vis; 2019; 25():625-635. PubMed ID: 31700227
[TBL] [Abstract][Full Text] [Related]
12. Estrogen induces estrogen-related receptor alpha gene expression and chromatin structural changes in estrogen receptor (ER)-positive and ER-negative breast cancer cells.
Hu P; Kinyamu HK; Wang L; Martin J; Archer TK; Teng C
J Biol Chem; 2008 Mar; 283(11):6752-63. PubMed ID: 18174157
[TBL] [Abstract][Full Text] [Related]
13. Oestrogen increases the activity of oestrogen receptor negative breast cancer stem cells through paracrine EGFR and Notch signalling.
Harrison H; Simões BM; Rogerson L; Howell SJ; Landberg G; Clarke RB
Breast Cancer Res; 2013 Mar; 15(2):R21. PubMed ID: 23497505
[TBL] [Abstract][Full Text] [Related]
14. Gremlin1 promotes carcinogenesis of glioma in vitro.
Guan Y; Cheng W; Zou C; Wang T; Cao Z
Clin Exp Pharmacol Physiol; 2017 Feb; 44(2):244-256. PubMed ID: 27862197
[TBL] [Abstract][Full Text] [Related]
15. Exercise-induced changes in tumour LDH-B and MCT1 expression are modulated by oestrogen-related receptor alpha in breast cancer-bearing BALB/c mice.
Aveseh M; Nikooie R; Aminaie M
J Physiol; 2015 Jun; 593(12):2635-48. PubMed ID: 25907793
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a novel small molecule subtype specific estrogen-related receptor alpha antagonist in MCF-7 breast cancer cells.
Chisamore MJ; Cunningham ME; Flores O; Wilkinson HA; Chen JD
PLoS One; 2009 May; 4(5):e5624. PubMed ID: 19462000
[TBL] [Abstract][Full Text] [Related]
17. Estrogen-related receptor-α promotes gallbladder cancer development by enhancing the transcription of Nectin-4.
Wang L; Yang M; Guo X; Yang Z; Liu S; Ji Y; Jin H
Cancer Sci; 2020 May; 111(5):1514-1527. PubMed ID: 32030850
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer.
Shou J; Massarweh S; Osborne CK; Wakeling AE; Ali S; Weiss H; Schiff R
J Natl Cancer Inst; 2004 Jun; 96(12):926-35. PubMed ID: 15199112
[TBL] [Abstract][Full Text] [Related]
19. The cannabinoid receptor inverse agonist AM251 regulates the expression of the EGF receptor and its ligands via destabilization of oestrogen-related receptor α protein.
Fiori JL; Sanghvi M; O'Connell MP; Krzysik-Walker SM; Moaddel R; Bernier M
Br J Pharmacol; 2011 Oct; 164(3):1026-40. PubMed ID: 21449913
[TBL] [Abstract][Full Text] [Related]
20. The enhanced expression of estrogen-related receptor α in human bladder cancer tissues and the effects of estrogen-related receptor α knockdown on bladder cancer cells.
Ye X; Guo J; Zhang H; Meng Q; Ma Y; Lin R; Yi X; Lu H; Bai X; Cheng J
J Cell Biochem; 2019 Aug; 120(8):13841-13852. PubMed ID: 30977157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
